Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-23-011221
Filing Date
2023-04-12
Accepted
2023-04-12 20:05:31
Documents
1
Period of Report
2023-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3691
  Complete submission text file 0000899243-23-011221.txt   5180
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SEATTLE GENETICS, INC. 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
HIMES VAUGHN B (Reporting) CIK: 0001361966 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-32405 | Film No.: 23816827